LONGEVA.
··

Semax: reference dosing schedule

> Updated:

Human schedule

Semax is used intranasally (0.1% drops or spray), with no injection or reconstitution. The following is a reference generalized from described studies and protocols.

This is a concise reference to regimens described for adults; it is not an individual prescription.

Semax nasal drops are usually searched for around one question, how many drops and how often, rather than the compound name itself; the table below answers that in concrete doses and course length.

Period / conditionDoseEscalation
Introductory regimen200–300 mcg per day (usually in the morning)Starting dose
Standard regimen300–600 mcg per day, split into 1–2 dosesIncrease if needed
Course10–30 days, then a 2–4 week breakMaximum in this schedule
Official label regimen (0.1% drops)600-900 mcg per day, 2-3 drops into each nostril 2-3 times a dayCourse of 7-10 days (labels on apteka911, mozdocs, manufacturer "Peptogen")
Practical dosing and effect details

In Manchenko and colleagues' study (Neuroscience and Behavioral Physiology, 2012), Semax was compared across different administration routes in rats: intranasal, intraperitoneal, and intramuscular. The nootropic and analgesic effect depended not only on dose but on how the peptide entered the body, meaning the route itself changed the outcome rather than being a minor technical detail.

That fits the logic of the intranasal schedule on this page: a short peptide with relatively fast metabolism is better sustained by frequent small doses (drops once or twice a day) than by an occasional large volume, which would mostly run off the mucosa rather than absorb.

That is also why the table above lists an 'introductory' regimen (200-300 mcg) separately from the higher manufacturer label regimen (600-900 mcg): these are two different sources for two different purposes, not conflicting numbers.

This is reference information from a preclinical study, not a medical recommendation and not instructions for self-administration.

This reference is research-use material. The information is not medical advice and is not intended for diagnosis, treatment or prevention of disease.